Total Payments
$8,521
2024 Payments
$1,179
Companies
36
Transactions
528
Medicare Patients
3,360
Medicare Billing
$378,779
Payment Breakdown by Category
Food & Beverage$8,390 (98.5%)
Education$130.84 (1.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,390 | 521 | 98.5% |
| Education | $130.84 | 3 | 1.5% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$8,521
524 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,538 | 172 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $844.30 | 54 | $0 (2024) |
| Celgene Corporation | $752.03 | 51 | $0 (2024) |
| Janssen Biotech, Inc. | $731.02 | 42 | $0 (2024) |
| PFIZER INC. | $535.65 | 36 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $490.96 | 28 | $0 (2024) |
| QOL Medical, LLC | $389.17 | 23 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $300.30 | 18 | $0 (2024) |
| Merck Sharp & Dohme LLC | $224.93 | 14 | $0 (2024) |
| Gilead Sciences, Inc. | $214.84 | 14 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,179 | 75 | ABBVIE INC. ($330.76) |
| 2023 | $1,327 | 85 | AbbVie Inc. ($306.48) |
| 2022 | $1,646 | 118 | ABBVIE INC. ($483.20) |
| 2021 | $1,776 | 117 | AbbVie Inc. ($645.44) |
| 2020 | $640.84 | 44 | AbbVie Inc. ($222.20) |
| 2019 | $802.24 | 46 | AbbVie, Inc. ($370.39) |
| 2018 | $496.12 | 18 | AbbVie, Inc. ($179.53) |
| 2017 | $652.91 | 25 | Valeant Pharmaceuticals North America LLC ($176.08) |
All Payment Transactions
528 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $26.45 | General |
| Category: Neuroscience | ||||||
| 08/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/28/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Immunology | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Gastroenterology | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $5.50 | General |
| Category: Gastroenterology | ||||||
| 08/27/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Gastroenterology | ||||||
| 08/14/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Immunology | ||||||
| 08/08/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Neuroscience | ||||||
| 08/07/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/06/2024 | Ferring Pharmaceuticals Inc. | CLENPIQ (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/05/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $20.29 | General |
| Category: THERAPY FOR CSID | ||||||
| 07/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Immunology | ||||||
| 07/11/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/08/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Gastroenterology | ||||||
| 07/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $31.39 | General |
| Category: IMMUNOLOGY | ||||||
| 07/01/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Neuroscience | ||||||
| 07/01/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $1.89 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/18/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Immunology | ||||||
| 06/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Gastroenterology | ||||||
| 06/11/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 647 | 959 | $526,116 | $67,362 |
| 2022 | 18 | 733 | 1,019 | $440,667 | $80,844 |
| 2021 | 19 | 1,104 | 1,795 | $389,945 | $125,858 |
| 2020 | 16 | 876 | 1,621 | $347,195 | $104,715 |
Total Patients
3,360
Total Services
5,394
Medicare Billing
$378,779
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 110 | 160 | $34,720 | $13,999 | 40.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 67 | 68 | $123,012 | $13,349 | 10.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 86 | 100 | $14,800 | $6,031 | 40.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 71 | 74 | $109,372 | $5,753 | 5.3% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 22 | 165 | $25,080 | $5,702 | 22.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 21 | 93 | $9,300 | $4,233 | 45.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $12,616 | $4,021 | 31.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 24 | $9,864 | $3,079 | 31.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 75 | 75 | $128,700 | $2,995 | 2.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 22 | 48 | $7,008 | $2,793 | 39.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 28 | 28 | $6,132 | $1,678 | 27.4% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 15 | 16 | $6,080 | $1,260 | 20.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $13,608 | $997.80 | 7.3% |
| 43450 | Dilation of esophagus | Facility | 2023 | 27 | 28 | $20,636 | $815.28 | 4.0% |
| 91200 | Measurement of liver stiffness | Office | 2023 | 29 | 30 | $5,188 | $653.10 | 12.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 156 | 256 | $50,400 | $22,099 | 43.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 86 | 93 | $151,684 | $7,512 | 5.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 65 | 65 | $17,969 | $6,854 | 38.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 45 | 115 | $15,536 | $6,193 | 39.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 91 | 109 | $14,248 | $6,091 | 42.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 31 | 31 | $42,000 | $5,956 | 14.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 38 | 39 | $12,813 | $5,868 | 45.8% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2022 | 12 | 27 | $18,696 | $5,015 | 26.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 48 | 48 | $51,098 | $3,637 | 7.1% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 14 | 65 | $9,880 | $2,302 | 23.3% |
About Dr. Patrick Sanchez, M.D
Dr. Patrick Sanchez, M.D is a Internal Medicine healthcare provider based in Columbia, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2013. The National Provider Identifier (NPI) number assigned to this provider is 1669812087.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Sanchez, M.D has received a total of $8,521 in payments from pharmaceutical and medical device companies, with $1,179 received in 2024. These payments were reported across 528 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($8,390).
As a Medicare-enrolled provider, Sanchez has provided services to 3,360 Medicare beneficiaries, totaling 5,394 services with total Medicare billing of $378,779. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Columbia, MS
- Active Since 06/29/2013
- Last Updated 03/25/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1669812087
Products in Payments
- ZEPOSIA (Drug) $727.95
- XIFAXAN (Drug) $670.98
- STELARA (Biological) $578.52
- HUMIRA (Biological) $542.34
- XELJANZ (Drug) $535.65
- RINVOQ (Biological) $373.90
- SUCRAID (Drug) $308.42
- LINZESS (Drug) $292.53
- Humira (Biological) $291.49
- OCALIVA (Drug) $267.79
- ENTYVIO (Biological) $259.27
- SKYRIZI (Biological) $248.60
- ZENPEP (Drug) $242.62
- MAVYRET (Drug) $223.88
- RELISTOR (Drug) $187.28
- DIFICID (Drug) $173.44
- REMICADE (Biological) $152.50
- CREON (Drug) $129.44
- Linzess (Drug) $128.42
- ERBE, VIO300D, APC2 (Device) $125.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Columbia
Dr. Mark Corriere, M.d, M.D
Internal Medicine — Payments: $499,000
Internal Medicine $499,000
Dr. David Nyanjom, M.d, M.D
Internal Medicine — Payments: $191,423
Internal Medicine $191,423
Dr. David Amrol, M.d, M.D
Internal Medicine — Payments: $144,633
Internal Medicine $144,633
Jake Krieg, M.d, M.D
Internal Medicine — Payments: $96,198
Internal Medicine $96,198
Donald Delwood, M.d, M.D
Internal Medicine — Payments: $72,250
Internal Medicine $72,250
Loren Morgan, Md, MD
Internal Medicine — Payments: $41,678
Internal Medicine $41,678